Published in Ann Intern Med on July 01, 1986
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent. J Exp Med (1987) 1.70
Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 1.53
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrob Agents Chemother (1993) 1.43
Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother (1987) 1.35
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 1.30
Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1990) 1.23
Potent antipneumocystis and antitoxoplasma activities of piritrexim, a lipid-soluble antifolate. Antimicrob Agents Chemother (1988) 1.19
Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1988) 1.02
Treatment of infection due to Pneumocystis carinii. Antimicrob Agents Chemother (1998) 1.01
Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. Antimicrob Agents Chemother (1995) 0.98
Effects of moderate-dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions. Antimicrob Agents Chemother (1997) 0.98
Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1988) 0.97
Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1996) 0.83
AIDS-related Pneumocystis carinii pneumonia successfully treated with dapsone-trimethoprim. Br J Clin Pharmacol (1988) 0.82
In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex. Antimicrob Agents Chemother (1998) 0.80
Drug usage evaluation of dapsone. Indian J Pharm Sci (2009) 0.78
AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome. Thorax (1990) 0.76
Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study. J Clin Aesthet Dermatol (2016) 0.75
The AIDS epidemic: blueprint of a hospital's response. Trans Am Clin Climatol Assoc (1988) 0.75
Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections. Br Med J (Clin Res Ed) (1988) 0.75
Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS. Can J Infect Dis (1991) 0.75
The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med (1994) 16.32
An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med (1992) 13.29
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet (1999) 10.06
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med (1993) 7.85
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 4.64
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med (1984) 4.46
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis (1987) 4.11
Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis (1998) 3.89
An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer (1978) 3.82
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med (1995) 3.80
The natural history of Hendra and Nipah viruses. Microbes Infect (2001) 3.77
Control strategies for tuberculosis epidemics: new models for old problems. Science (1996) 3.59
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med (1988) 3.49
Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med (1992) 3.39
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med (1999) 3.26
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 3.17
The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 2.92
Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet (1985) 2.88
Rectal bleeding. Do other symptoms aid in diagnosis? Dis Colon Rectum (1989) 2.83
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet (1987) 2.68
Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis (2009) 2.68
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2011) 2.50
Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol (1979) 2.48
Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology (1995) 2.41
Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis (1998) 2.35
The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet (1996) 2.35
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis (2009) 2.19
Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis (1987) 2.19
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax (2013) 2.17
Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16
Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis (1987) 2.09
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis (2000) 2.04
Mycobacteria and AIDS mortality. Am Rev Respir Dis (1989) 2.02
Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res (1975) 2.02
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 1.96
Review of University of British Columbia Family Practice Resident Research Projects 1990-1997. Fam Med (1999) 1.94
Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology (1978) 1.93
Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (1997) 1.92
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89
Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses (1987) 1.86
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J Infect Dis (1971) 1.78
Role of gastrin supersensitivity in the pathogenesis of lower esophageal sphincter hypertension in achalasia. J Clin Invest (1971) 1.77
Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun (1987) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med (2000) 1.71
Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis (1990) 1.71
Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med (1993) 1.70
Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med (1997) 1.70
Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1998) 1.69
Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings. Am Rev Respir Dis (1989) 1.68
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.66
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am Rev Respir Dis (1991) 1.64
Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest (1997) 1.64
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Clinical utility of a commercial test based on the polymerase chain reaction for detecting Mycobacterium tuberculosis in respiratory specimens. Am J Respir Crit Care Med (1995) 1.62
Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis (1986) 1.61
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis (1990) 1.60
Why is it so hard to dissociate multivalent antigens from cell-surface antibodies? Immunol Today (1996) 1.57
Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission. Int J Tuberc Lung Dis (1997) 1.57
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
Experimental asbestosis with four types of fibers: importance of small particles. Ann N Y Acad Sci (1965) 1.55
Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis (1990) 1.55
Tuberculosis in patients with end-stage renal disease. Am J Med (1980) 1.54
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53
Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52
The adult respiratory distress syndrome. Annu Rev Med (1976) 1.51
Influenza in patients with human immunodeficiency virus infection. Chest (1990) 1.50
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1994) 1.50
Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis (1999) 1.49
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49